Institut für Biochemie CC2, Charité - Universitätsmedizin Berlin, Oudenarder Strasse 16, 13347 Berlin, Germany.
Mol Cell. 2010 Oct 8;40(1):147-58. doi: 10.1016/j.molcel.2010.09.012.
Coordinated regulation of the ubiquitin-proteasome system (UPS) is crucial for the cell to adjust its protein degradation capacity to changing proteolytic requirements. We have shown previously that mammalian cells upregulate proteasome gene expression in response to proteasome inhibition. Here, we report the identification of the transcription factor TCF11 (long isoform of Nrf1) as a key regulator for 26S proteasome formation in human cells to compensate for reduced proteolytic activity. Under noninducing conditions, TCF11 resides in the endoplasmic reticulum (ER) membrane. There, TCF11 is targeted to ER-associated protein degradation requiring the E3 ubiquitin ligase HRD1 and the AAA ATPase p97. Proteasome inhibitors trigger the accumulation of oxidant-damaged proteins and promote the nuclear translocation of TCF11 from the ER, permitting activation of proteasome gene expression by binding to antioxidant response elements in their promoter regions. Thus, we uncovered the transcriptional control loop regulating human proteasome-dependent protein degradation to counteract proteotoxic stress caused by proteasome inhibition.
泛素-蛋白酶体系统(UPS)的协调调节对于细胞根据不断变化的蛋白水解需求来调整其蛋白降解能力至关重要。我们之前已经表明,哺乳动物细胞会在蛋白酶体受到抑制时上调蛋白酶体基因的表达。在这里,我们报告了转录因子 TCF11(Nrf1 的长型异构体)作为人细胞中 26S 蛋白酶体形成的关键调节剂的鉴定,以补偿降低的蛋白水解活性。在非诱导条件下,TCF11 位于内质网(ER)膜上。在那里,TCF11 被靶向到需要 E3 泛素连接酶 HRD1 和 AAA ATP 酶 p97 的 ER 相关蛋白降解。蛋白酶体抑制剂会引发氧化损伤蛋白的积累,并促进 TCF11 从 ER 向核内易位,从而允许其通过结合到启动子区域中的抗氧化反应元件来激活蛋白酶体基因的表达。因此,我们揭示了调节人类依赖蛋白酶体的蛋白降解的转录控制回路,以抵消由蛋白酶体抑制引起的蛋白毒性应激。